RxDoctor Payments Data

Shannon Bunch, APRN

Nurse Practitioner · Corbin, KYNPI 1649576562

Payments from drug & device makers

$1,680in general payments, 2019–2025

Across 107 payments — averaging $15.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$320
  • Amgen$281
  • Lilly USA, LLC$234
  • AstraZeneca$165
  • Exact Sciences$102
  • Merck$76
  • plus $503 from 14 others

What the payments were for

  • Food & beverage$1,680100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,680 in reported general payments places this provider in the 75th percentile of 1,918 nurse practitioner providers in Kentucky.

See all nurse practitioner providers in Kentucky

Medicare billing

Part B allowed, 2024
$3,526
Medicare patients
29
Services billed
144

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide56$61,509
OzempicSemaglutide37$33,313
JardianceEmpagliflozin24$27,235
Breztri AerosphereBudesonide/Glycopyr/Formoterol22$16,704
LinzessLinaclotide14$11,932
EliquisApixaban15$8,456
Dexlansoprazole DrDexlansoprazole14$2,866
Levothyroxine Sodium121$1,595
Ventolin HfaAlbuterol Sulfate13$1,404
Celecoxib55$1,402
Atorvastatin Calcium154$1,208
Pantoprazole Sodium109$996
Losartan Potassium91$827
SynthroidLevothyroxine Sodium11$730
Rosuvastatin Calcium95$646

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$234$61,50956 claims
Novo NordiskOzempic$75$33,31337 claims
Boehringer IngelheimJardiance$26$27,23524 claims
AstraZenecaBreztri Aerosphere$165$16,70422 claims
AbbVieLinzess, Synthroid$320$12,66225 claims
PfizerEliquis$67$8,45615 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,918 nurse practitioner providers in Kentucky.

Other nurse practitioner in Corbin

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →